Sage Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sage Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $10M | 477k | 21.67 |
| 2023-09-30 | $6.4M | 313k | 20.58 |
| 2023-06-30 | $24M | 512k | 47.02 |
| 2023-03-31 | $40M | 946k | 41.96 |
| 2022-12-31 | $36M | 946k | 38.14 |
| 2022-06-30 | $36M | 1.1M | 32.30 |
| 2022-03-31 | $10M | 314k | 33.10 |
| 2021-12-31 | $19M | 453k | 42.54 |
| 2021-09-30 | $21M | 473k | 44.31 |
| 2021-03-31 | $36M | 477k | 74.85 |
| 2020-12-31 | $58M | 666k | 86.51 |
| 2020-09-30 | $33M | 533k | 61.12 |
| 2020-06-30 | $34M | 813k | 41.58 |
| 2019-12-31 | $38M | 525k | 72.19 |
| 2019-09-30 | $46M | 331k | 140.29 |
| 2019-06-30 | $62M | 340k | 183.09 |
| 2019-03-31 | $52M | 327k | 159.05 |
| 2018-12-31 | $26M | 267k | 95.79 |
| 2018-09-30 | $32M | 224k | 141.25 |
| 2018-06-30 | $66M | 423k | 156.53 |
| 2018-03-31 | $52M | 325k | 161.07 |
| 2017-12-31 | $55M | 332k | 164.71 |
| 2017-09-30 | $35M | 555k | 62.30 |
| 2017-06-30 | $88M | 1.1M | 79.64 |
| 2017-03-31 | $12M | 162k | 71.07 |
| 2016-12-31 | $7.9M | 154k | 51.06 |
| 2016-09-30 | $14M | 312k | 46.05 |
| 2016-06-30 | $8.6M | 286k | 30.13 |
| 2016-03-31 | $4.1M | 129k | 32.06 |
| 2015-12-31 | $11M | 182k | 58.29 |
| 2015-09-30 | $6.4M | 152k | 42.33 |
| 2015-06-30 | $2.5M | 34k | 72.99 |
| 2015-03-31 | $235k | 4.7k | 50.20 |
| 2014-12-31 | $1.2M | 34k | 36.59 |